BreastCancerTrials.org

Expanded Access is an FDA program that allows a patient to receive an investigational drug outside of a clinical trial. Learn more about the Expanded Access Program, how to find expanded access drugs, and how to apply for the program on Metastatic Trial Talk. We feature content from U.S. Food and Drug Administration, Reagan-Udall Foundation for the FDA, and Pfizer.

Because of new research, doctors and patients question if the current screening guidelines for breast cancer brain mets are up-to-date. Continue reading to learn about the pros and cons of screening for breast cancer brain metastases in people with advanced breast cancer. This edition of Metastatic Trial Talk includes articles from Verywell, CURE magazine, Imaging Technology News - ITN Cancer Today.

See all clinical trials for DCIS and stage I through III breast cancer that were added to BreastCancerTrials.org during the last two weeks.